Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Completed · Not applicable

Conditions studied: Hepatic Malignancies

In brief

The purpose of this study is to compare the results of positron emission tomography/computer tomography (PET/CT) to positron emission tomography/magnetic resonance imaging (PET/MRI) to help determine any added advantage of one over the other in relation to a tumor which might assist in further management plans.

Key facts

Study ID

NCT04332419

Run by

Case Comprehensive Cancer Center

People needed

11

Starts

2020-03-03

Expected to finish

2020-09-21

Last updated by the study team

2022-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient has a liver malignancy and is scheduled for SIRT with Y-90; AND
• The patient is an adult, self-competent, and able to provide informed consent to participate in the study

You may not qualify if…

• The patient loses competence, has a condition that questions their ability to provide informed consent independently (e.g. cannot communicate in English), or withdraws consent to participate within any time in the study period; OR
• The patient is not eligible to undergo MRI due to the presence of metal devices or implants in their body; OR
• Both imaging modalities cannot take place within 6 hours after Y-90 RE; OR
• Both imaging modalities cannot take place within 1 hour apart from each other

Where it is running

• Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.